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CC BY-NC-ND license (http://creativeBackground/Purpose: As routine diagnostic assays for human parechoviruses (HPeVs) have not
been included in the enteroviruses surveillance network in Taiwan, HPeVs may be the actual
pathogens of hundreds of untypeable enteroviruses-suspected isolates.
Methods: In this study, these untypeable isolates collected from 2007 through 2012 were
examined by reverse transcription-polymerase chain reaction (RT-PCR)-based methods to sur-
vey the epidemiology of HPeVs in Taiwan.
Results: Thirty-eight HPeV isolates were identified from 575 untypeable isolates, including 23
HPeV type1 (HPeV1), 13 HPeV3, and two HPeV6. Most of the patients were Taiwanese children
under 5 years of age and their infections were generally prevalent in summer and autumn, with
the highest peak occurring in September. The ratio of male to female patients was 1.56 and
2.25 for HPeV1 and HPeV3, respectively. Fever and respiratory symptoms were reported in
significantly more patients infected with HPeV1. The results of phylogenetic analyses showed
that HPeV isolates between 2007 and 2012 belonged to different lineages, indicating that
endemic circulation of HPeV existed in Taiwan.
Conclusion: This study showed that HPeVs have been endemic in Taiwan for some years despite
a low positive rate. The detection tests of HPeVs are needed to correct a diagnostic deficit inesearch, Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and




Society of Microbiology. Published by Elsevier Taiwan LLC. This is an open access article under the
commons.org/licenses/by-nc-nd/4.0/).
322 Y.-P. Huang et al.the surveillance system. The epidemiological and genetic information obtained from the pre-
sent study would contribute to the understanding of the etiology and epidemiology of HPeVs.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Human parechovirus (HPeV) contains a positive-sense, sin-
gle-stranded RNA genome, and belongs to the family of
Picornaviridae and the genus of Parechovirus.1,2 There are
16 known genotypes in the genus Parechovirus, namely
HPeV1e16 (http://www.picornaviridae.com/parechovirus/
hpev/hpev.htm). Discovered in 1956, HPeV1 and HPeV2
were formerly classified as echovirus 22 and 23 in the genus
Enterovirus, respectively.1,2 HPeV3 was firstly identified
from a 1-year-old child with transient paralysis, high fever,
and diarrhea in Japan.3 HPeV4 was isolated in 2002 from a
neonate with fever and Toxoplasmosis, other agents,
rubella, cytomegalovirus, and herpes simplex (TORCH)
syndrome in The Netherlands.4 HPeV5 was identified in the
USA,5,6 and HPeV6 was isolated from a 1-year-old child with
Reye’s syndrome in Japan.7 Recently, as the surveillance
system and molecular detection methods have become
wildly adopted, more varieties of HPeV genotypes have
been identified.
Parechovirus infections have been associated with a
wide variety of gastrointestinal, respiratory, and central
nervous system clinical symptoms. Previous studies re-
ported that HPeV infections detected in young children
were the commonly identified genotypes HPeV1 and
HPeV3.8,9 A recent study in Iran reported that 112/472
samples (23.7%) were HPeV1-positive using a reverse
transcription-polymerase chain reaction (RT-PCR) method.
The incidence and prevalence of HPeV infection was higher
in the spring and autumn, and in the male population.8 The
median age of children infected with HPeV1 was signifi-
cantly higher than those infected with HpeV3 (6.6 months
vs. 1.3 months, respectively).10 Recent data also showed
that HPeV3 infections were restricted to children under the
age of 3 months, and were associated with fever, menin-
gitis, and viremia more frequently than those with HPeV1
infections.11,12
The Taiwan Virology Reference Laboratory Network was
set up by Taiwan Centers for Disease Control (Taiwan CDC)
in 1999 in cooperation with virological laboratories of 13
major medical centers and physicians.13 The network
covers all four cardinal regions of Taiwan, and was set up
mainly for surveillance of enterovirus and influenza virus
infections. However, HPeV was not included as a routine
diagnostic assay in this surveillance network, and hundreds
of isolates were reported as untypeable enteroviruses each
year after standard enterovirus identification procedures
that may be identifiable as HPeV.14 In this study, these
untypeable isolates collected from 2007 through 2012 were
reexamined by RT-PCR-based methods to survey the
epidemiology of HPeV and/or other etiological agents in
Taiwan.Materials and methods
Ethics statement
The project was reviewed and approved by the Institutional
Review Board (IRB) of Taiwan CDC (IRB No. 101011).
Virus isolation
Throat swabs or other samples (rectal swabs, stools, sera or
cerebrospinal fluid specimens) from suspected enterovirus
cases were collected, and the viruses were isolated
following the standard operational protocols for entero-
virus surveillance system conducted by Taiwan CDC as
previously described.15 The virus isolates were then iden-
tified by immunofluorescence assay (IFA) using commercial
antibodies against enterovirus, adenovirus, and herpes
simplex virus (Light Diagnostics, Millipore Corporation,
Billerica, MA, USA) according to the manufacturer’s proto-
col. IFA-untypeable isolates were then sent to Taiwan CDC
for further RT-PCR assays and sequencing.
RNA extraction and RT-PCR amplification
RNA was extracted using QIAamp Viral RNA Mini Kit (Qiagen,
Santa Clara, CA, USA) according to the manufacturer’s in-
structions. A conventional RT-PCR method or an enterovirus
Consensus-Degenerate Hybrid Oligonucleotide Primers
(CODEHOP) method was used to identify enteroviruses.16e18
Real-time PCR targeting the 50 nontranslated region was
applied to detect the members of the genus Parechovirus
when the initial result was inconclusive.19 Semi-nested PCR
was further performed to amplify the complete viral pro-
tein 1 (VP1) sequences of HPeV, once the positive reaction
was obtained by the specific RT-PCR assay.20 The Basic
Local Alignment Search Tool (BLAST) was used for virus
classification and genotyping using the reference sequence
database in GenBank.21
Phylogenetic analysis
The nucleotide and deduced amino acid sequences of the
VP1 region were aligned using the BioEdit program (Ibis
Biosciences, Carlsbad, CA, USA).22 The phylogenetic tree
was constructed by MEGA program (version 5) using the
maximum-likelihood method with a bootstrap value of
1000.23 An amino acid substitution map was performed
based on the entropy values of VP1 sequences, and only the
amino acids with values >0.5 were shown. Different amino
acid residues were indicated by different colors with single-
letter abbreviations.
Table 1 Characteristics of cases infected with human
parechovirus (HPeV), 2007e2012
Type Sex Age (y) Total
Female Male <1 1e5 >5
HPeV1 9 14 6 17 0 23
HPeV3 4 9 2 8 3 13
HPeV6 1 1 0 2 0 2
Total 14 24 8 27 3 38
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Clinical data were obtained from medical records as part of
the Taiwan CDC compulsory infectious disease surveillance
system. The patient’s age, sex, and illnesses were recor-
ded. The patient’s clinical symptoms were scored as the
following characteristics: fever, respiratory symptoms
(cough, rhinorrhea, sore throat, or respiratory infections),
and gastrointestinal symptoms (diarrhea, vomiting, or
abdominal distention). Clinical symptoms were compared
using Fisher’s exact test. A p value <0.05 was considered
statistically significant in all analyses.
Nucleotide sequence accession numbers
Thirty-eight HPeV sequences were generated in this study
and deposited into GenBank. The accession numbers of
these isolates are KC887287eKC887324.
Results
Virus identification
Final typing results based on IFA, molecular detection
methods, and BLAST are shown in Fig. 1. A total of 575
untypeable virus isolates between 2007 and 2012 were
reexamined in this study. Among them, 231 enteroviruses
(40 human enterovirus A species, 105 human enterovirus B
species, 33 human enterovirus C species, and 53 human
enterovirus D species), 162 human rhinoviruses, 33 HPeVs,
five mixed infections (coxsackievirus B4/HPeV3, entero-
virus 71/HPeV1, 2 coxsackievirus B3/HPeV1, and coxsack-
ievirus A10/HPeV3), and eight other viruses (2 adenovirus, 2
herpes simplex virus, one Chikungunya virus, and 3 Saffold
virus) were identified (Fig. 1).
Epidemiology and clinical data
Thirty-eight HPeV isolates including 23 HPeV1, 13 HPeV3,
and two HPeV6 were identified in this study (Table 1);
among them five HPeVs were found in mixed infections.Figure 1. Identification of untypeable enterovirus-suspected isolHPeV1 was the most common dominant genotype of HPeV
infection in Taiwan based on this study.
The annual trend of HPeV detection from 2007 to 2012 is
shown in Fig. 2. Both HPeV1 and HPeV3 were found in 2007,
2011, and 2012. There was slightly more HPeV3 infection
(n Z 6) than HPeV1 infection (n Z 3) in 2007, but signifi-
cantly more HPeV1 infection than HPeV3 infection in 2012
(nZ 13 vs nZ 2, respectively). Both HPeV6 infection cases
were detected in 2008 and none was found thereafter.
Coincident with a flu pandemic outbreak in Taiwan, no
HPeV infection was identified in 2009.
Patients infected with HPeV (n Z 38, mean Z 48.4
months) were significantly younger than those infected
with identifiable non-polio enteroviruses (n Z 1260,
mean Z 95.6 months, p Z 0.001; data not shown). Nearly
92% (35/38) of the HPeV infected patients were under 5
years of age. The mean age of HPeV1-infected patients
(n Z 23) was 29.3 months and those infected with HPeV3
(n Z 13) was 86.2 months. There was no statistically sig-
nificant difference between the age of the children infec-
ted with HPeV1 and HPeV3 (p Z 0.16); and on further
exclusion the three HPeV3 patients over 5 years old did not
change the conclusion (mean age 29.3 vs. 27.4 months,
p > 0.05).
The ratio of male to female patients infected with
HPeV1 and HPeV3 was 1.56 and 2.25, respectively. In
addition, a greater frequency of HPeV infections was
observed in summer and autumn, with the highest peak in
September (Table 1 and Fig. 3).
Clinical symptoms of HPeV1 and HPeV3 infected patients
are summarized in Table 2. In general, fever was the mostates. HEVZ human enterovirus; HPeVZ human parechovirus.
Figure 2. Distribution of human parechovirus types in Taiwan during 2007e2012.
Figure 3. Seasonal distribution of human parechovirus type 1 (HPeV1), 3 (HPeV3), and 6 (HPeV6) infections in Taiwan,
2007e2012.
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tients, followed by respiratory and gastrointestinal symp-
toms. No sepsis or neurological symptoms were reported in
this study. Further comparisons showed that fever and
respiratory symptoms were more frequently observed inTable 2 Clinical symptoms of human parechovirus (HPeV)
infection in Taiwan, 2007e2012
Characteristic No. of patients with
symptoms/no. of patients (%)
p
HPeV1 HPeV3
Fever 23/23 (100) 10/13 (77) 0.04*
Respiratory
symptoms
19/23 (83) 3/13 (23) <0.001*
Gastrointestinal
symptoms
4/23 (17) 0/13 (0) 0.27
*Statistically significant.HPeV1-infected patients than in HPeV3-infected patients
(p Z 0.04 and p < 0.001, respectively).
Phylogenetic analysis of HPeV
The majority of the HPeV isolates in Taiwan (n Z 23) has
been HPeV1, with sequence similarity ranging from 74% to
77% when compared to the HPeV1 prototype strain Harris
based on its nucleotide sequences of the VP1 region.
However, they clustered closely with recently genotyped
HPeV1 sequences including Japanese, Chinese, Korean, and
German strains. Among these, 12 isolates in 2011e2012
showed a high identity with each other, indicating endemic
circulation of HPeV1 in Taiwan. In addition, two constant
amino acid substitutions (residue 78 and 92) were observed
in these 12 isolates (Figs. 4 and 5).
The HPeV3 isolates in Taiwan (n Z 13) were 91e92%
homologous to the HPeV3 prototype strain A308/99, and
grouped in two lineages. Among these, five isolates in 2007
were more closely related to the Japanese isolates in
2006e2008, but the other seven isolates in 2011e2012 and
Figure 4. Phylogenetic analysis of human parechoviruses (HPeV) based on the VP1 gene sequence. The phylogenetic tree was
constructed with MEGA software (Version 5) by the maximum-likelihood method using 1000 bootstrap replications. Only bootstrap
values >70% are shown. The Taiwan HPeV isolates are indicated by triangles. BRA Z Brazil; CAN Z Canada; CHN Z China;
FRA Z France; DEU Z Germany; HUN Z Hungary; JPN Z Japan; KOR Z South Korea; NLD Z The Netherlands; PAK Z Pakistan;
TWN Z Taiwan; USA Z United States.
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one unique amino acid substitution (residue 67 K/R) was
observed in the latter lineage (Figs. 4 and 6). High identity
was observed among the HPeV6 isolates, and the Taiwan
isolates were closely related to the Chinese strain, SH6 (97%
homology; Fig. 4).Our results showed that clustering of HPeV1 or HPeV3
isolates in Taiwan was independent from the date of sample
collection, geographical distribution, or clinical features. In
other words, there was no significant difference in the
distribution of these factors among different HPeV1 or
HPeV3 clusters. However, due to the limitation of small
Figure 5. Phylogenetic analysis of human parechoviruses type 1 (HPeV1) in Taiwan based on the VP1 gene sequence. The
phylogenetic tree was constructed with MEGA software (Version 5) by the maximum-likelihood method using 1000 bootstrap
replications. Only bootstrap values >70% are shown. Amino acid substitutions are visualized through a proteotyping map labeled by
different colors. Each column represents the amino acid position indicated, and only entropy values >0.5 are shown.
326 Y.-P. Huang et al.sample size, we cannot rule out the possibility that such an
association actually exists. Thus, further confirmation of
this observation is required.Discussion
HPeVs deserve more attention, not only because they
distribute worldwide and show high genetic heterogeneity,
but also because certain viral types could cause central
nervous system (CNS) symptoms in young children. This
study has revealed that a number of cell cultures collected
during enterovirus surveillance by Taiwan Virology Refer-
ence Laboratory Network from 2007 to 2012 are HPeV
cases. In total, 575 of these isolates were further tested by
HPeV-specific PCR assays, more sensitive enterovirus PCR
assays, and IFA for herpes simplex virus and adenovirus. The
presence of 38 HPeV-positive isolates revealed the diag-
nostic deficit in enterovirus surveillance. However, because
HPeV is not yet routinely diagnosed in the Taiwan Virology
Reference Laboratory Network, the prevalence of HPeV in
Taiwan is suspected to be underestimated.In this study, both HPeV1 and HPeV3 infections were
most prevalent in summer and autumn, but various sea-
sonal distribution patterns were observed in other studies.
A low level of HPeV1 occurred in The Netherlands in the
summer, the incidence of Iranian HPeV1 was higher in the
spring and autumn, and the Dutch HPeV3 isolates were
isolated in spring and the early summer.8,10,11 Japanese
HPeV1 strains were detected predominantly during autumn
and winter, whereas HPeV3 strains were detected during
summer and autumn.24 By contrast, a prospective birth
cohort study in Finland observed HPeV infections clustered
around autumn and showed no obvious changes between
1996 and 2007,25 and another Chinese study reported a
peak in summer to autumn in hospitalized children.26
Previous studies demonstrated that HPeV1 was associ-
ated with mild respiratory or gastrointestinal disease, and
HPeV3 was found more frequently in children with severe
clinical symptoms,10,12 but the phenomenon was not found
in this study. In contrast to previous observations, our
analysis showed that fever and respiratory symptoms were
observed more often in HPeV1-infected patients than in
HPeV3-infected patients. Both discordant results may be
Figure 6. Phylogenetic analysis of human parechoviruses type 3 (HPeV3) in Taiwan based on the VP1 gene sequence. The
phylogenetic tree was constructed with MEGA software (Version 5) by the maximum-likelihood method using 1000 bootstrap
replications. Only bootstrap values >70% are shown. Amino acid substitutions are visualized through a proteotyping map labeled by
different colors. Each column represents the amino acid position indicated, and only entropy values >0.5 are shown.
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the point mutations of HPeV strains and susceptible popu-
lation in Taiwan. More studies are needed to clarify the
impact of HPeV type on the severity of infection, clinical
presentation, as well as seasonal distribution.
Three Saffold virus isolates were detected by
enterovirus-specific RT-PCR in this study. This is not sur-
prising because the Saffold virus and enterovirus both
belong to the family Picornaviridae.
Many virus isolates in IFA screening were reported as
untypeable enteroviruses, either due to artificial mistakes,
or the limitation of the commercial IFA kit, i.e., many se-
rotypes of enteroviruses are not yet covered by the re-
agents and could not be identified. In this study, the
serotypes/genotypes of 231 enterovirus isolates were
further examined and confirmed by enterovirus-specific RT-
PCR and BLAST. Although molecular detection assays pro-
vide more accurate results than IFA methods, IFA methods
could still be used as a preliminary screening tool for clin-
ical laboratories.27 For the detection of HPeV, given the
poor growth in culture and antigenic typing, reagents are
not widely available for HPeV; molecular detection assays,
which show higher sensitivity and specificity, and are the
more promising methods.
These HPeV isolates between 2007 and 2012 belonged to
different lineages, indicating endemic circulation of HPeV in
Taiwan. HPeV3 isolates in Taiwan showed generally less ge-
netic diversity than did HPeV1 isolates, and the mean
Tajima-Nei distances were 0.041 and 0.157 in HPeV3 and
HPeV1 sequences, respectively, indicating a more recent
source for HPeV3 isolates (Fig. 4). Based on the results of
sequence comparison, two constant amino acid substitutions
(residue 78 and 92 in the VP1 region) were observed in half of
the Taiwan HPeV1 isolates (13/23; Fig. 5). By contrast, oneunique amino acid substitution (residue 67) was observed in
the Taiwan HPeV3 isolates (Fig. 6). These results indicated
the genetic evolution of endemic HPeV strains. In addition,
the arginine-glycine-aspartic acid motif, a key factor in
defining cellular tropisms, was also found in Taiwan HPeV1
and HPeV6 isolates but absent in HPeV3 isolates.28,29 How-
ever, clustering of these HPeV isolates in Taiwan could not be
readily related to clinical features. More studies are needed
to associate the severity of HPeV infection with sequence
variations in any genotypes.
In conclusion, firstly, this study shows that HPeV has
been endemic in Taiwan for some years despite a low
positive rate. Secondly, the detection tests of HPeV are
needed to correct a diagnostic deficit in the surveillance
system. Thirdly, the epidemiological and genetic informa-
tion obtained from the present study contribute to under-
standing the etiology and epidemiology of HPeV.Conflicts of interest
The authors declare that they have no conflicts of interest.Acknowledgments
The authors would like to thank all principal investigators,
physicians, and colleagues of the Taiwan CDC Collaborating
Laboratories of Virology. This study was supported finan-
cially by research grants from the Taiwan CDC (DOH100-DC-
2019, DOH101-DC-2401 and DOH102-DC-2601) and the Na-
tional Research Program for Genomic Medicine (98-0324-01-
F-20 and 99-0324-01-F-12). The findings and conclusions in
this study are those of the authors and do not necessarily
328 Y.-P. Huang et al.represent the views of the Taiwan Centers for Disease
Control.
References
1. Harvala H, Simmonds P. Human parechoviruses: biology,
epidemiology and clinical significance. J Clin Virol 2009;45:
1e9.
2. Stanway G, Joki-Korpela P, Hyypia T. Human parechovir-
usesebiology and clinical significance. Rev Med Virol 2000;10:
57e69.
3. Ito M, Yamashita T, Tsuzuki H, Takeda N, Sakae K. Isolation and
identification of a novel human parechovirus. J Gen Virol 2004;
85:391e8.
4. Benschop KS, Schinkel J, Luken ME, van den Broek PJ,
Beersma MF, Menelik N, et al. Fourth human parechovirus
serotype. Emerging Infect Dis 2006;12:1572e5.
5. Oberste MS, Maher K, Pallansch MA. Complete sequence of
echovirus 23 and its relationship to echovirus 22 and other
human enteroviruses. Virus Res 1998;56:217e23.
6. Al-Sunaidi M, Williams CH, Hughes PJ, Schnurr DP, Stanway G.
Analysis of a new human parechovirus allows the definition of
parechovirus types and the identification of RNA structural
domains. J Virol 2007;81:1013e21.
7. Watanabe K, Oie M, Higuchi M, Nishikawa M, Fujii M. Isolation
and characterization of novel human parechovirus from clinical
samples. Emerging Infect Dis 2007;13:889e95.
8. Ghazi F, Ataei Z, Dabirmanesh B. Molecular detection of human
parechovirus type 1 in stool samples from children with diar-
rhea. Int J Infect Dis 2012;16:e673e6.
9. Mizuta K, Kuroda M, Kurimura M, Yahata Y, Sekizuka T, Aoki Y,
et al. Epidemic myalgia in adults associated with human par-
echovirus type 3 infection, Yamagata, Japan, 2008. Emerging
Infect Dis 2012;18:1787e93.
10. Benschop KS, Schinkel J, Minnaar RP, Pajkrt D, Spanjerberg L,
Kraakman HC, et al. Human parechovirus infections in Dutch
children and the association between serotype and disease
severity. Clin Infect Dis 2006;42:204e10.
11. van der Sanden S, de Bruin E, Vennema H, Swanink C,
Koopmans M, van der Avoort H. Prevalence of human par-
echovirus in the Netherlands in 2000 to 2007. J Clin Microbiol
2008;46:2884e9.
12. Harvala H, Robertson I, Chieochansin T, McWilliam Leitch EC,
Templeton K, et al. Specific association of human parechovirus
type 3 with sepsis and fever in young infants, as identified by
direct typing of cerebrospinal fluid samples. J Infect Dis 2009;
199:1753e60.
13. Wu TN, Tsai SF, Li SF, Lee TF, Huang TM, Wang ML, et al.
Sentinel surveillance for enterovirus 71, Taiwan, 1998.
Emerging Infect Dis 1999;5:458e60.
14. Tseng FC, Huang HC, Chi CY, Lin TL, Liu CC, Jian JW, et al.
Epidemiological survey of enterovirus infections occurring inTaiwan between 2000 and 2005: analysis of sentinel physician
surveillance data. J Med Virol 2007;79:1850e60.
15. Huang YP, Lin TL, Hsu LC, Chen YJ, Tseng YH, Hsu CC, et al.
Genetic diversity and C2-like subgenogroup strains of entero-
virus 71, Taiwan, 2008. Virol J 2010;7:277.
16. Nix WA, Oberste MS, Pallansch MA. Sensitive, seminested PCR
amplification of VP1 sequences for direct identification of all
enterovirus serotypes from original clinical specimens. J Clin
Microbiol 2006;44:2698e704.
17. Oberste MS, Maher K, Kilpatrick DR, Flemister MR, Brown BA,
Pallansch MA. Typing of human enteroviruses by partial
sequencing of VP1. J Clin Microbiol 1999;37:1288e93.
18. Oberste MS, Nix WA, Maher K, Pallansch MA. Improved molec-
ular identification of enteroviruses by RT-PCR and amplicon
sequencing. J Clin Virol 2003;26:375e7.
19. Nix WA, Maher K, Johansson ES, Niklasson B, Lindberg AM,
Pallansch MA, et al. Detection of all known parechoviruses by
real-time PCR. J Clin Microbiol 2008;46:2519e24.
20. Nix WA, Maher K, Pallansch MA, Oberste MS. Parechovirus
typing in clinical specimens by nested or semi-nested PCR
coupled with sequencing. J Clin Virol 2010;48:202e7.
21. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local
alignment search tool. J Mol Biol 1990;215:403e10.
22. Hall TA. BioEdit: a user-friendly biological sequence alignment
editor and analysis program for Windows 95/98/NT. Nucleic
Acids Symp Ser 1999;41:95e8.
23. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S.
MEGA5: molecular evolutionary genetics analysis using
maximum likelihood, evolutionary distance, and maximum
parsimony methods. Mol Biol Evol 2011;28:2731e9.
24. Ito M, Yamashita T, Tsuzuki H, Kabashima Y, Hasegawa A,
Nagaya S, et al. Detection of humanparechoviruses fromclinical
stool samples in Aichi, Japan. J Clin Microbiol 2010;48:2683e8.
25. Kolehmainen P, Oikarinen S, Koskiniemi M, Simell O, Ilonen J,
Knip M, et al. Human parechoviruses are frequently detected in
stool of healthy Finnish children. J Clin Virol 2012;54:156e61.
26. Guo Y, Duan Z, Qian Y. Changes in human parechovirus profiles
in hospitalized children with acute gastroenteritis after a
three-year interval in Lanzhou, China. PLoS One 2013;8:
e68321.
27. Lin TL, Li YS, Huang CW, Hsu CC, Wu HS, Tseng TC, et al. Rapid
and highly sensitive coxsackievirus A indirect immunofluores-
cence assay typing kit for enterovirus serotyping. J Clin
Microbiol 2008;46:785e8.
28. Benschop KS, Williams CH, Wolthers KC, Stanway G,
Simmonds P. Widespread recombination within human par-
echoviruses: analysis of temporal dynamics and constraints. J
Gen Virol 2008;89:1030e5.
29. Benschop K, Thomas X, Serpenti C, Molenkamp R, Wolthers K.
High prevalence of human Parechovirus (HPeV) genotypes in
the Amsterdam region and identification of specific HPeV var-
iants by direct genotyping of stool samples. J Clin Microbiol
2008;46:3965e70.
